相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The mercurial nature of neutrophils: still an enigma in ARDS?
Andrew E. Williams et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
Fernando J. Martinez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
WNT/β-Catenin Signaling Induces IL-1β Expression by Alveolar Epithelial Cells in Pulmonary Fibrosis
Verena Aumiller et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Plasma B Lymphocyte Stimulator and B Cell Differentiation in Idiopathic Pulmonary Fibrosis Patients
Jianmin Xue et al.
JOURNAL OF IMMUNOLOGY (2013)
Preclinical SPECT/CT Imaging of αvβ6 Integrins for Molecular Stratification of Idiopathic Pulmonary Fibrosis
Alison E. John et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for Active Disease
Ruoqi Peng et al.
PLOS ONE (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pirfenidone should be prescribed for patients with idiopathic pulmonary fibrosis
Gisli Jenkins
THORAX (2013)
Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis
Kristina Rydell-Tormanen et al.
LABORATORY INVESTIGATION (2012)
Hot off the breath: triple therapy for idiopathic pulmonary fibrosis-hear the PANTHER roar
Emmet E. McGrath et al.
THORAX (2012)
TRANSCRIPTIONAL MECHANISMS REGULATING EXPRESSION OF THE AVB6 INTEGRIN IN IPF
A. L. Tatler et al.
THORAX (2012)
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
Luba Nalysnyk et al.
EUROPEAN RESPIRATORY REVIEW (2012)
Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis
Michael A. Gibbons et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Endothelin in Pulmonary Fibrosis
Carmen Fonseca et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Novel therapeutic approaches for pulmonary fibrosis
Arnab Datta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis
Laura Arribillaga et al.
CYTOKINE (2011)
Secretoglobin 3A2 Suppresses Bleomycin-induced Pulmonary Fibrosis by Transforming Growth Factor β Signaling Down-regulation
Reiko Kurotani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
Static and dynamic mechanics of the murine lung after intratracheal bleomycin
Effrosyni D. Manali et al.
BMC PULMONARY MEDICINE (2011)
Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis
Amber L. Degryse et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Potential Role of Endothelin-1 in Pulmonary Fibrosis From the Bench to the Clinic
Bryan Ross et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
The Human Carnitine Transporter SLC22A16 Mediates High Affinity Uptake of the Anticancer Polyamine Analogue Bleomycin-A5
Mustapha Aouida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Transplantation of Human Embryonic Stem Cell-Derived Alveolar Epithelial Type II Cells Abrogates Acute Lung Injury in Mice
Dachun Wang et al.
MOLECULAR THERAPY (2010)
Definition of the intermediates and mechanism of the anticancer drug bleomycin using nuclear resonance vibrational spectroscopy and related methods
Lei V. Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis
Pamela Gasse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
WNT5A Is a Regulator of Fibroblast Proliferation and Resistance to Apoptosis
Louis J. Vuga et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Role of the Chemokine Receptor CXCR2 in Bleomycin-Induced Pulmonary Inflammation and Fibrosis
Remo C. Russo et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Pivotal Role of Connective Tissue Growth Factor in Lung Fibrosis MAPK-Dependent Transcriptional Activation of Type I Collagen
Markella Ponticos et al.
ARTHRITIS AND RHEUMATISM (2009)
Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis
T. Izumo et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Early and Late Changes of MMP-2 and MMP-9 in Bleomycin-Induced Pulmonary Fibrosis
Ji Young Kim et al.
YONSEI MEDICAL JOURNAL (2009)
Animal models of acute lung injury
Gustavo Matute-Bello et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis
Benjamin D. Bringardner et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression
M. Molina-Molina et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis
Anna Serrano-Mollar et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Endothelin is a downstream mediator of profibrotic responses to transforming growth factor β in human lung fibroblasts
Xu Shi-wen et al.
ARTHRITIS AND RHEUMATISM (2007)
Molecular targets in pulmonary fibrosis - The myofibroblast in focus
Chris J. Scotton et al.
CHEST (2007)
Therapies for bleomycin induced lung fibrosis through regulation of TGF-β1 induced collagen gene expression
Kenneth R. Cutroneo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: Autocrine mechanisms in myofibroblasts and macrophages
Bruce D. Uhal et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-β in the lung
K. Nakagome et al.
THORAX (2006)
Idiopathic pulmonary fibrosis: an update
O. J. Dempsey et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2006)
Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis
M. Molina-Molina et al.
THORAX (2006)
Direct hydrogen-atom abstraction by activated bleomycin: An experimental and computational study
A Decker et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Relationship of BAL and lung tissue CD4+ and CD8+ T lymphocytes, and their ratio in idiopathic pulmonary fibrosis
SA Papiris et al.
CHEST (2005)
CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis -: art. no. 81
Z Daniil et al.
RESPIRATORY RESEARCH (2005)
Bleomycin-induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2
BB Moore et al.
JOURNAL OF IMMUNOLOGY (2005)
Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation
GR Grotendorst et al.
FASEB JOURNAL (2005)
Interferon-β inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-β and thrombospondin
A Azuma et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Cell profiles of bronchoalveolar lavage fluid as prognosticators of idiopathic pulmonary fibrosis/usual interstitial pneumonia among Japanese patients
RP Tabuena et al.
RESPIRATION (2005)
Attenuation of bleomycin induced pulmonary fibrosis in mice using the heme oxygenase inhibitor Zn-deuteroporphyrin IX-2,4-bisethylene glycol
L Atzori et al.
THORAX (2004)
Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation
GR Grotendorst et al.
FASEB JOURNAL (2004)
Regulation of PDGF and its receptors in fibrotic diseases
JC Bonner
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis
HF Nadrous et al.
CHEST (2004)
Transforming growth factor-β antagonizes alveolar type II cell proliferation induced by keratinocyte growth factor
FJ Zhang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases
T Okuma et al.
JOURNAL OF PATHOLOGY (2004)
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs
E Cavarra et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Integrin αvβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1
JP Annes et al.
JOURNAL OF CELL BIOLOGY (2004)
Smad3 mediates transforming growth factor-β-induced α-smooth muscle actin expression
B Hu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo
XP Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2
BB Moore et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours
JM O'Sullivan et al.
ANNALS OF ONCOLOGY (2003)
Idiopathic pulmonary fibrosis: new insights in its pathogenesis
A Pardo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent
V Lama et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Interleukin-1β stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-β-dependent mechanism
DA Vesey et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2002)
The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis
AG Nicholson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
TGF-β1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells
N Hagimoto et al.
JOURNAL OF IMMUNOLOGY (2002)
Time course of bleomycin-induced lung fibrosis
G Izbicki et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2002)
Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells
TH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of the effects of TGF-β1 by activation of latent TGF-β1 and differential expression of TGF-β receptors (TβR-I and TβR-II) in idiopathic pulmonary fibrosis
N Khalil et al.
THORAX (2001)
Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis
M Gharaee-Kermani et al.
CYTOKINE (2001)
Transforming growth factor-β signal transduction in epithelial cells
JB Yue et al.
PHARMACOLOGY & THERAPEUTICS (2001)
Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis
G Borzone et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway
O Tounekti et al.
BRITISH JOURNAL OF CANCER (2001)
Different expression of endothelin in the Bronchoalveolar lavage in patients with pulmonary diseases
F Reichenberger et al.
LUNG (2001)
Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis
T Maeyama et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP)
JV Barbas-Filho et al.
JOURNAL OF CLINICAL PATHOLOGY (2001)
Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation
SN Iyer et al.
INFLAMMATION (2000)
Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis
M Fujii et al.
THROMBOSIS RESEARCH (2000)
Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice
S Hagiwara et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Interleukin-1β and tumor necrosis factor-α decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro
DA Siwik et al.
CIRCULATION RESEARCH (2000)
Bleomycin-mediated pulmonary toxicity - Evidence for a p53-mediated response
A Mishra et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
Role of E-selectin in bleomycin induced lung fibrosis in mice
A Azuma et al.
THORAX (2000)
Bleomycin: New perspectives on the mechanism of action
SM Hecht
JOURNAL OF NATURAL PRODUCTS (2000)